Triple-negative breast cancer (TNBC) is diagnosed based on the negativity of all three receptors that are found in other breast cancer types: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor (HER-2). Here, ESR1 is linked to triple-negative breast carcinoma.